振东制药（300158）8月22日主力资金净流入3299.62万元

Group 1 - The core viewpoint of the news highlights the recent performance and financial metrics of Zhendong Pharmaceutical, indicating a slight increase in stock price and a notable decline in net profit [1] - As of August 22, 2025, Zhendong Pharmaceutical's stock closed at 8.38 yuan, up 1.33%, with a trading volume of 617,100 hands and a transaction amount of 513 million yuan [1] - The company reported total revenue of 755 million yuan for Q1 2025, a year-on-year decrease of 3.53%, while net profit attributed to shareholders was 1.1572 million yuan, down 94.99% [1] Group 2 - The company has a current liquidity ratio of 3.026 and a quick ratio of 2.345, indicating strong short-term financial health [1] - Zhendong Pharmaceutical has invested in 33 enterprises and participated in 741 bidding projects, showcasing its active engagement in the market [2] - The company holds 34 trademark registrations and 103 patents, along with 128 administrative licenses, reflecting its commitment to intellectual property and regulatory compliance [2]